upndown1313

Downturn Has Transformed Drug Company Business Model

Write facts, but wrong interpretation. Big Pharma spending at CRO probably hasn't changed much, but rather the smaller, more virtual biotechs who have dramtically cut back on their spending due to the lack of funds and lack of access to credit markets due to the credit crunch.